1Pirozynski M. 100 years of lung cancer. Respir Med, 2006, 100: 2073 -2084.
2Gomez M, Silvestri GA. Lung cancer screening. Am J Med Sci, 2008, 335: 46-50.
3Sone S,Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomograpy scancer. Lancet, 1998, 351 : 1242-1245.
4Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology, 1996, 201 : 798-802.
5Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung canceraction project : overall design and findings from baseline screening. Lancet, 1999, 354: 99-105.
6CassidyA, Duffy SW, Myles JP, et al. Lung cancer risk prediction: a tool for early detection. Int J Cancer, 2007, 120: 1-6.
8Sone S, Nakayama T, Honda T, et al. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer, 2007, 58 : 329-341.
9Geus-Oei LF, Oyen WJ. Predictive and prognostic value of FDG-PET. Cancer Imaging, 2008, 8 : 70-80.
10Mansueto M, Grimaldi A, Torbica A, et al. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [ (18F) ] fluorodeoxyglucose PET and CT comparison. Q J Nucl Med Mol Imaging, 2007, 51 : 224-234.
